Genomic Prediction
PrivateLast Round
Series A
Extension
Dec 15, 2021
Total Funding Raised
$16.5M
Company Overview
Genomic Prediction is a biotechnology company that provides advanced genomic tests which improve in-vitro fertilization (IVF) health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomic Prediction Comparables
Compare Genomic Prediction with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orchid Health | 93% | |
| Reprocare Genetics | 87% | |
| Juno Genetics | 86% |
Genomic Prediction Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 15, 2021 | ||||
| Series A | Jan 31, 2019 |
Key People
Founding team and executive leadership
Genomic Prediction Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NimbleVentures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Santiago Munné appointed as Chief Scientific Officer.
- Oct 23, 2025
Accused of trade secret misappropriation by Nucleus Genomics.
Genomic Prediction Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access